Found 6 hits for monomerid = 50220017 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Amine oxidase (flavin-containing) A
(Homo sapiens (Human)) | BDBM50220017
![PNG](/data/jpeg/tenK5022/BindingDB_50220017.png) ((5R)-3-(3-fluoro-4-{6-[(4-methyl-1H-imidazol-1-yl)...)Show SMILES Cc1cn(CC(=O)c2ccc(cn2)-c2ccc(cc2F)N2C[C@H](Cn3ccnn3)OC2=O)cn1 Show InChI InChI=1S/C23H20FN7O3/c1-15-10-29(14-26-15)13-22(32)21-5-2-16(9-25-21)19-4-3-17(8-20(19)24)31-12-18(34-23(31)33)11-30-7-6-27-28-30/h2-10,14,18H,11-13H2,1H3/t18-/m0/s1 | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >5.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human liver MAOA expressed in yeast |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50220017
![PNG](/data/jpeg/tenK5022/BindingDB_50220017.png) ((5R)-3-(3-fluoro-4-{6-[(4-methyl-1H-imidazol-1-yl)...)Show SMILES Cc1cn(CC(=O)c2ccc(cn2)-c2ccc(cc2F)N2C[C@H](Cn3ccnn3)OC2=O)cn1 Show InChI InChI=1S/C23H20FN7O3/c1-15-10-29(14-26-15)13-22(32)21-5-2-16(9-25-21)19-4-3-17(8-20(19)24)31-12-18(34-23(31)33)11-30-7-6-27-28-30/h2-10,14,18H,11-13H2,1H3/t18-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2C19 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50220017
![PNG](/data/jpeg/tenK5022/BindingDB_50220017.png) ((5R)-3-(3-fluoro-4-{6-[(4-methyl-1H-imidazol-1-yl)...)Show SMILES Cc1cn(CC(=O)c2ccc(cn2)-c2ccc(cc2F)N2C[C@H](Cn3ccnn3)OC2=O)cn1 Show InChI InChI=1S/C23H20FN7O3/c1-15-10-29(14-26-15)13-22(32)21-5-2-16(9-25-21)19-4-3-17(8-20(19)24)31-12-18(34-23(31)33)11-30-7-6-27-28-30/h2-10,14,18H,11-13H2,1H3/t18-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50220017
![PNG](/data/jpeg/tenK5022/BindingDB_50220017.png) ((5R)-3-(3-fluoro-4-{6-[(4-methyl-1H-imidazol-1-yl)...)Show SMILES Cc1cn(CC(=O)c2ccc(cn2)-c2ccc(cc2F)N2C[C@H](Cn3ccnn3)OC2=O)cn1 Show InChI InChI=1S/C23H20FN7O3/c1-15-10-29(14-26-15)13-22(32)21-5-2-16(9-25-21)19-4-3-17(8-20(19)24)31-12-18(34-23(31)33)11-30-7-6-27-28-30/h2-10,14,18H,11-13H2,1H3/t18-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2C9 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 1A
(Homo sapiens (Human)) | BDBM50220017
![PNG](/data/jpeg/tenK5022/BindingDB_50220017.png) ((5R)-3-(3-fluoro-4-{6-[(4-methyl-1H-imidazol-1-yl)...)Show SMILES Cc1cn(CC(=O)c2ccc(cn2)-c2ccc(cc2F)N2C[C@H](Cn3ccnn3)OC2=O)cn1 Show InChI InChI=1S/C23H20FN7O3/c1-15-10-29(14-26-15)13-22(32)21-5-2-16(9-25-21)19-4-3-17(8-20(19)24)31-12-18(34-23(31)33)11-30-7-6-27-28-30/h2-10,14,18H,11-13H2,1H3/t18-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP1A2 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50220017
![PNG](/data/jpeg/tenK5022/BindingDB_50220017.png) ((5R)-3-(3-fluoro-4-{6-[(4-methyl-1H-imidazol-1-yl)...)Show SMILES Cc1cn(CC(=O)c2ccc(cn2)-c2ccc(cc2F)N2C[C@H](Cn3ccnn3)OC2=O)cn1 Show InChI InChI=1S/C23H20FN7O3/c1-15-10-29(14-26-15)13-22(32)21-5-2-16(9-25-21)19-4-3-17(8-20(19)24)31-12-18(34-23(31)33)11-30-7-6-27-28-30/h2-10,14,18H,11-13H2,1H3/t18-/m0/s1 | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca Discovery
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2D6 |
J Med Chem 50: 4868-81 (2007)
Article DOI: 10.1021/jm070428+ BindingDB Entry DOI: 10.7270/Q2SX6CX0 |
More data for this Ligand-Target Pair | |